Works about PYRAZINAMIDE

Results: 582

Design, Synthesis, and In Vitro Evaluation of 4-(Arylchalcogenyl)methyl)-1H-1,2,3-triazol-1-yl-menadione: Exploring Their Potential Against Tuberculosis.

Published in:

Pharmaceuticals (14248247), 2025, v. 18, n. 6, p. 797, doi. 10.3390/ph18060797

By:

Santos, Nathália L. B.;
Gomes, Luana S.;
Ribeiro, Ruan C. B.;
Carvalho, Alcione S. de;
Lourenço, Maria Cristina S.;
Marins, Laís Machado;
Valle, Sandy Polycarpo;
Doring, Thiago H.;
Andricopulo, Adriano D.;
Oliveira, Aldo S. de;
Ferreira, Vitor F.;
da Silva, Fernando de C.;
Forezi, Luana da Silva Magalhães;
Nascimento, Vanessa

Publication type:

Article

Delayed and Unreported Drug-Susceptibility Testing Results in the US National Tuberculosis Surveillance System, 1993-2014.

Published in:

Public Health Reports, 2017, v. 132, n. 4, p. 480, doi. 10.1177/0033354917708989

By:

Jones, Jefferson Michael;
Armstrong, Lori R.

Publication type:

Article

Quantification of pyrazinamide, isoniazid, acetyl‐isoniazid, and rifampicin by a high‐performance liquid chromatography method in human plasma from patients with tuberculosis.

Published in:

Journal of Separation Science, 2021, v. 44, n. 2, p. 521, doi. 10.1002/jssc.202000672

By:

Hernández‐González, Oswaldo;
Zarazúa, Sergio;
Veytia‐Bucheli, José Ignacio;
González‐Chávez, Marco Martín;
Rodríguez‐Pinal, Cristian Jazmín;
Medellín‐Garibay, Susanna Edith;
Uresti‐Rivera, Edith Elena;
Pérez‐Vázquez, Francisco Javier;
Portales‐Pérez, Diana Patricia;
Romano‐Moreno, Silvia;
Milán‐Segovia, Rosa del Carmen

Publication type:

Article

Identification of Five New Minor Constituents from the Whole Plant of Amischotolype hispida.

Published in:

Helvetica Chimica Acta, 2015, v. 98, n. 3, p. 347, doi. 10.1002/hlca.201400179

By:

Chang, Chun-Wei;
Chen, Ih-Sheng;
Chang, Hsun-Shuo;
Cheng, Ming-Jen;
Peng, Chien-Fang

Publication type:

Article

Acute histoplasmosis in three Mexican sewer workers.

Published in:

Occupational Medicine, 2013, v. 63, n. 1, p. 77, doi. 10.1093/occmed/kqs191

By:

Santos, L.;
Santos-Martínez, G.;
Magaña-Ortíz, J. E.;
Puente-Piñón, S. L.

Publication type:

Article

Anti-Tuberculous Drug Copper Pyrazinamide: Synthesis, Characterization, Theoretical DFT, Bioactivity and Toxicity Studies in the Liver.

Published in:

Journal of Computational Biophysics & Chemistry, 2023, v. 22, n. 6, p. 655, doi. 10.1142/S2737416523500333

By:

Olawale, Margaret D.;
Ola-Mudathir, Fausat K.;
Akintemi, Eric O.;
Obaleye, Joshua A.

Publication type:

Article

Inclusion complexes of β-cyclodextrin with pyrazinamide and piperazine: Crystallographic and theoretical studies.

Published in:

Supramolecular Chemistry, 2009, v. 21, n. 5, p. 384, doi. 10.1080/10610270802061184

By:

Aree, Thammarat;
Chaichit, Narongsak

Publication type:

Article

Pyrazinamide enhances lipid peroxidation and antioxidant levels to induce liver injury in rat models through PI3k/Akt inhibition.

Published in:: Toxicology Research, 2020, v. 9, n. 3, p. 149, doi. 10.1093/toxres/tfaa015
Publication type:: Article

Pyrazinamide-induced hepatotoxicity and gender differences in rats as revealed by a <sup>1</sup>H NMR based metabolomics approach.

Published in:

Toxicology Research, 2017, v. 6, n. 1, p. 17, doi. 10.1039/c6tx00245e

By:

Zhao, He;
Si, Zhi-Hong;
Li, Ming-Hui;
Jiang, Lei;
Fu, Yong-Hong;
Xing, Yue-Xiao;
Hong, Wei;
Ruan, Ling-Yu;
Li, Pu-Ming;
Wang, Jun-Song

Publication type:

Article

Design and Synthesis of Imidazole and Triazole Pyrazoles as Mycobacterium Tuberculosis CYP121A1 Inhibitors.

Published in:

ChemistryOpen, 2019, v. 8, n. 7, p. 995, doi. 10.1002/open.201900227

By:

Kishk, Safaa M.;
McLean, Kirsty J.;
Sood, Sakshi;
Smith, Darren;
Evans, Jack W.D.;
Helal, Mohamed A.;
Gomaa, Mohamed S.;
Salama, Ismail;
Mostafa, Samia M.;
de Carvalho, Luiz Pedro S.;
Levy, Colin W.;
Munro, Andrew W.;
Simons, Claire

Publication type:

Article

Lung cavitation due to Mycobacterium xenopi in a renal transplant recipient.

Published in:

Transplant Infectious Disease, 2009, v. 11, n. 3, p. 249, doi. 10.1111/j.1399-3062.2009.00376.x

By:

Martín-Penagos, L.;
Rodrigo, E.;
Ruíz, J. C.;
Agüero, J.;
Fernandez-Mazarrasa, C.;
Martínez, L.;
Piñera, C.;
Arias, M.

Publication type:

Article

The production and sales of anti-tuberculosis drugs in China.

Published in:

Infectious Diseases of Poverty, 2016, v. 3, p. 1, doi. 10.1186/s40249-016-0184-z

By:

Yang-Mu Huang;
Qi-Peng Zhao;
Qiao-Meng Ren;
Dan-Lu Peng;
Yan Guo

Publication type:

Article

Bioequivalence and Pharmacokinetic Evaluation of 2 Pyrazinamide Formulations in Healthy Chinese Adults: A Single‐Dose, Open‐Label, Randomized‐Sequence, 2×2 Crossover Study.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 4, p. 551, doi. 10.1002/cpdd.1035

By:

Wang, Siyang;
Ren, Jian;
Wang, Hongxia;
Zhi, Tingting;
Zhu, Yuanyuan;
Feng, Jinxin;
Li, Zhen;
Zhang, Ruiqin

Publication type:

Article

CYP2E1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity: a nested case-control study.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2012, v. 37, n. 5, p. 588, doi. 10.1111/j.1365-2710.2012.01334.x

By:

Tang, S.-W.;
Lv, X.-Z.;
Zhang, Y.;
Wu, S.-S.;
Yang, Z.-R.;
Xia, Y.-Y.;
Tu, D.-H.;
Deng, P.-Y.;
Ma, Y.;
Chen, D.-F.;
Zhan, S.-Y.

Publication type:

Article

Exfoliated dermatitis and hepatitis to first line anti-tubercular therapy with treatment of drug-sensitive tuberculosis with second line anti-tubercular therapy: a roller coaster ride.

Published in:

2024

By:

Spalgais, Sonam;
Safwan M., Ahmed;
Mrigpuri, Parul;
Kumar, Raj

Publication type:

Case Study

Possible rifampicin-induced arthritis in a patient receiving anti-tuberculosis therapy: the first reported case.

Published in:

2024

By:

Chowdhury, Rahaymin;
Safdar, Nawaz Z;
Ellames, Deborah A B;
Wakefield, Richard J

Publication type:

Case Study

A scaly plaque on the left buttock.

Published in:

Clinical & Experimental Dermatology, 2013, v. 38, n. 3, p. 324, doi. 10.1111/j.1365-2230.2012.04466.x

By:

Shim, T. N.;
Tsang, Y. W.;
Snead, D.;
Ilchyshyn, A.

Publication type:

Article

Cutaneous miliary resistant tuberculosis in a patient infected with human immunodeficiency virus: case report and literature review.

Published in:

Clinical & Experimental Dermatology, 2009, v. 34, n. 8, p. e690, doi. 10.1111/j.1365-2230.2009.03425.x

By:

Regnier, S.;
Ouagari, Z.;
Perez, Z. L.;
Veziris, N.;
Bricaire, F.;
Caumes, E.

Publication type:

Article

A REVIEW ON ADVERSE EVENT STUDY ON ANTI-TUBERCULAR DRUGS.

Published in:

International Journal of Pharmacy & Life Sciences, 2016, v. 7, n. 9, p. 38

By:

Sharma, Pragya;
Arora, Rashmi;
Dubey, Raghvendra

Publication type:

Article

Effect of Carum carvi, a herbal bioenhancer on pharmacokinetics of antitubercular drugs: A study in healthy human volunteers.

Published in:

Perspectives in Clinical Research, 2014, v. 5, n. 2, p. 80, doi. 10.4103/2229-3485.128027

By:

Choudhary, Naiyma;
Khajuria, Vijay;
Gillani, Zahid H.;
Tandon, Vishal R.;
Arora, Ekta

Publication type:

Article

Oküer Tüberküoz II: Tanı ve Tedavi.

Published in:

Turkish Journal of Ophthalmology / Turk Oftalmoloji Dergisi, 2011, v. 41, n. 3, p. 182, doi. 10.4274/tjo.41.847560

By:

Onal, Sumru;
Tugal-Tutkun, ‹lknur

Publication type:

Article

Anti-tuberculosis drugs decrease viability and stimulate the expression of chondrocyte marker genes in human nucleus pulposus cells.

Published in:

Molecular Medicine Reports, 2014, v. 9, n. 1, p. 316, doi. 10.3892/mmr.2013.1767

By:

LEHMANN, TOMASZ P.;
GŁOWACKI, MACIEJ;
MISTERSKA, EWA;
WALCZAK, MICHAŁ;
JAGODZIŃSKI, PAWEŁ P.;
GŁOWACKI, JAKUB

Publication type:

Article

Non-Immediate Type Hypersensitivity Reactions with First-Line Antituberculosis Drugs and Diagnostic Patch Testing.

Published in:

Asthma Allergy Immunology / Astim Allerji Immunoloji, 2024, v. 22, n. 2, p. 181, doi. 10.21911/aai.2024.601

By:

BUHARI, Gozde KOYCU;
BAHCECIOGLU, Sakine NAZIK;
GULTUNA, Selcan;
ERCELEBI, Dilek CUHADAR;
DEMIR, Senay;
TUGLU, Hatice CELIK;
TELLI, Onur;
AKSU, Kurtulus

Publication type:

Article

From the Centers for Disease Control and Prevention. Fatal and severe hepatitis associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection--New York and Georgia, 2000.

Published in:: 2001
Publication type:: journal article

Discovery of New Isoniazid Derivatives As Anti-tubercular Agents: In silico Studies, Synthesis, and In vitro Activity Evaluation.

Published in:

Oriental Journal of Chemistry, 2023, v. 39, n. 6, p. 1510, doi. 10.13005/ojc/390610

By:

MOHD, ABIDA ASH;
IMRAN, MOHD;
ALNASER, NOURA YOUSIF;
ALTIMYAT, SHAMS SAUD;
AL-OTAIBI, NAWAF M.;
BAWADEKJI, ABDULHAKIM

Publication type:

Article

Squamous Cell Carcinoma Arising From Lupus Vulgaris On The Neck.

Published in:

Duzce Medical Journal, 2011, v. 13, n. 2, p. 45

By:

YILDIRIM, Muzaffer;
ERDEM, Teoman;
ALİAĞAOĞLU, Cihangir

Publication type:

Article

Antituberculosis potential of borrelidin derivatives: An in silico molecular docking and molecular dynamic approach.

Published in:

Thai Journal of Pharmaceutical Sciences, 2025, v. 49, n. 1, p. 1

By:

Ernawati, Teni;
Ramadhan, Donny;
Hermawan, Faris;
Wulyoadi, Sasmito;
Marwoto, Bambang;
Wibisana, Ahmad;
Srijanto, Bambang

Publication type:

Article

Pyrazinamide resistance in rifampicin discordant tuberculosis.

Published in:

PLoS ONE, 2022, v. 17, n. 9, p. 1, doi. 10.1371/journal.pone.0274688

By:

Mvelase, Nomonde Ritta;
Singh, Ravesh;
Swe Swe-Han, Khine;
Mlisana, Koleka Patience

Publication type:

Article

Comparison of different regimens with or without fluoroquinolone in isoniazid-resistant tuberculosis: A multicenter cohort study.

Published in:

PLoS ONE, 2022, v. 17, n. 8, p. 1, doi. 10.1371/journal.pone.0273263

By:

Min, Jinsoo;
Kim, Hyung Woo;
Kang, Ji Young;
Kim, Sung Kyoung;
Kim, Jin Woo;
Kim, Yong Hyun;
Yoon, Hyoung Kyu;
Lee, Sang Haak;
Kim, Ju Sang

Publication type:

Article

Shotgun proteomic profiling of dormant, 'non-culturable' Mycobacterium tuberculosis.

Published in:

PLoS ONE, 2022, v. 17, n. 8, p. 1, doi. 10.1371/journal.pone.0269847

By:

Nikitushkin, Vadim;
Shleeva, Margarita;
Loginov, Dmitry;
Dyčka F., Filip;
Sterba, Jan;
Kaprelyants, Arseny

Publication type:

Article

Antitubercular activity assessment of fluorinated chalcones, 2-aminopyridine-3-carbonitrile and 2-amino-4H-pyran-3-carbonitrile derivatives: In vitro, molecular docking and in-silico drug likeliness studies.

Published in:

PLoS ONE, 2022, v. 17, n. 6, p. 1, doi. 10.1371/journal.pone.0265068

By:

Lagu, Surendra Babu;
Yejella, Rajendra Prasad;
Nissankararao, Srinath;
Bhandare, Richie R.;
Golla, Venu Sampath;
Subrahmanya Lokesh, Bontha Venkata;
Rahman, M. Mukhlesur;
Shaik, Afzal Basha

Publication type:

Article

Safety of 3 Different Reintroduction Regimens of Antituberculosis Drugs after Development of Antituberculosis Treatment-Induced Hepatotoxicity.

Published in:

Clinical Infectious Diseases, 2010, v. 50, n. 6, p. 833, doi. 10.1086/650576

By:

Sharma, Surendra K.;
Singla, Rohit;
Sarda, Pawan;
Mohan, Alladi;
Makharia, Govind;
Jayaswal, Arvind;
Sreenivas, Vishnubhatla;
Singh, Sarman

Publication type:

Article

Isoniazid, Rifampin, Ethambutol, and Pyrazinamide Pharmacokinetics and Treatment Outcomes among a Predominantly HIV-Infected Cohort of Adults with Tuberculosis from Botswana.

Published in:

Clinical Infectious Diseases, 2009, v. 48, n. 12, p. 1685, doi. 10.1086/599040

By:

Chideya, Sekai;
Winston, Carla A.;
Peloquin, Charles A.;
Bradford, William Z.;
Hopewell, Philip C.;
Wells, Charles D.;
Reingold, Arthur L.;
Kenyon, Thomas A.;
Moeti, Themba L.;
Tappero, Jordan W.

Publication type:

Article

Clinical Characteristics and Treatment Outcomes of Patients with Isoniazid-Monoresistant Tuberculosis.

Published in:

Clinical Infectious Diseases, 2009, v. 48, n. 2, p. 179, doi. 10.1086/595689

By:

Cattamanchi, Adithya;
Dantes, Raymund B.;
Metcalfe, John Z.;
Jarlsberg, Leah G.;
Grinsdale, Jennifer;
Kawamura, L. Masae;
Osmond, Dennis;
Hopewell, Philip C.;
Nahid, Payam

Publication type:

Article

Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial.

Published in:

2019

By:

Lee, Myungsun;
Mok, Jeongha;
Kim, Deog Kyeom;
Shim, Tae Sun;
Koh, Won-Jung;
Jeon, Doosoo;
Lee, Taehoon;
Lee, Seung Heon;
Kim, Ju Sang;
Park, Jae Seuk;
Lee, Ji Yeon;
Kim, Song Yee;
Lee, Jae Ho;
Jo, Kyung-Wook;
Jhun, Byung Woo;
Kang, Young Ae;
Ahn, Joong Hyun;
Kim, Chang-Ki;
Shin, Soyoun;
Song, Taeksun

Publication type:

journal article

Preparative ion exchange purification of capreomycin from fermentation broth produced by Streptomyces capreolus.

Published in:

Journal of Liquid Chromatography & Related Technologies, 2021, v. 44, n. 7/8, p. 364, doi. 10.1080/10826076.2021.1938116

By:

Subramanian, Sunu;
Patil, Mahendra;
Ingle, Umesh;
Lali, Arvind

Publication type:

Article

Development and validation of a RP-HPLC method for simultaneous quantification of bedaquiline (TMC207), moxifloxacin and pyrazinamide in a pharmaceutical powder formulation for inhalation.

Published in:

Journal of Liquid Chromatography & Related Technologies, 2018, v. 41, n. 8, p. 415, doi. 10.1080/10826076.2018.1437748

By:

Momin, Mohammad A. M.;
Rangnekar, Bhamini;
Das, Shyamal C.

Publication type:

Article

Transfer of Minilab TLC Screening Methods to Quantitative HPTLC-Densitometry for Pyrazinamide, Ethambutol, Isoniazid, and Rifampicin in a Combination Tablet.

Published in:

Journal of Liquid Chromatography & Related Technologies, 2015, v. 38, n. 11, p. 1126, doi. 10.1080/10826076.2015.1028292

By:

Strock, Jacob;
Nguyen, Mai;
Sherma, Joseph

Publication type:

Article

Formulation and Characterization of Pyrazinamide Polymeric Nanoparticles for Pulmonary Tuberculosis: Efficiency for Alveolar Macrophage Targeting.

Published in:

Indian Journal of Pharmaceutical Sciences, 2015, v. 77, n. 3, p. 258, doi. 10.4103/0250-474X.159602

By:

RAVI VARMA, J. N.;
KUMAR, T. SANTOSH;
PRASANTHI, B.;
RATNA, J. VIJAYA

Publication type:

Article

Olfactory disturbance related to pyrazinamide.

Published in:

QJM: An International Journal of Medicine, 2014, v. 107, n. 3, p. 217, doi. 10.1093/qjmed/hct186

By:

Tsou, C.-C.;
Chien, J.-Y.

Publication type:

Article

Mycobacterium chelonae infection involving the auricle.

Published in:

QJM: An International Journal of Medicine, 2012, v. 105, n. 10, p. 1021, doi. 10.1093/qjmed/hcr165

By:

Lin, Y.-H.;
Liu, T.-C.

Publication type:

Article

Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.

Published in:

2019

By:

Al-Mutairi, Noura M.;
Ahmad, Suhail;
Mokaddas, Eiman;
Eldeen, Hanaa S.;
Joseph, Susan

Publication type:

journal article

Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.

Published in:

2017

By:

Yu Pang;
Zhu, Damian;
Huiwen Zheng;
Jing Shen;
Yan Hu;
Jie Liu;
Yanlin Zhao;
Pang, Yu;
Zheng, Huiwen;
Shen, Jing;
Hu, Yan;
Liu, Jie;
Zhao, Yanlin

Publication type:

journal article

Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia.

Published in:

2017

By:

Sengstake, Sarah;
Bergval, Indra L.;
Schuitema, Anja R.;
de Beer, Jessica L.;
Phelan, Jody;
de Zwaan, Rina;
Clark, Taane G.;
van Soolingen, Dick;
Anthony, Richard M.

Publication type:

journal article

Discovery of a Pyrimidinedione Derivative with Potent Inhibitory Activity against Mycobacterium tuberculosis Ketol–Acid Reductoisomerase.

Published in:

Chemistry - A European Journal, 2021, v. 27, n. 9, p. 3130, doi. 10.1002/chem.202004665

By:

Lin, Xin;
Kurz, Julia L.;
Patel, Khushboo M.;
Wun, Shun Jie;
Hussein, Waleed M.;
Lonhienne, Thierry;
West, Nicholas P.;
McGeary, Ross P.;
Schenk, Gerhard;
Guddat, Luke W.

Publication type:

Article

Stereoselective Synthesis of Complex Polyenes through Sequential α‐/β‐C−H Functionalization of trans‐Styrenes.

Published in:

Angewandte Chemie, 2024, v. 136, n. 12, p. 1, doi. 10.1002/ange.202315273

By:

Zhu, Yuhang;
Wang, Yini;
Shen, Wenzhou;
Chen, Xiaoyu;
Liu, Qiuhua;
Yang, Limin;
Zhong, Guofu;
Zhang, Jian

Publication type:

Article

The influence of tuberculosis treatment on efavirenz clearance in patients co-infected with HIV and tuberculosis.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 5, p. 689, doi. 10.1007/s00228-011-1166-5

By:

Gengiah, Tanuja;
Holford, Nicholas;
Botha, Julia;
Gray, Andrew;
Naidoo, Kogieleum;
Abdool Karim, Salim

Publication type:

Article

Antituberculosis Therapy–Associated Cutaneous Leukocytoclastic Vasculitis.

Published in:

Journal of Tropical Pediatrics, 2013, v. 59, n. 6, p. 507, doi. 10.1093/tropej/fmt048

By:

Bhatia, Vidyut;
Sibal, Anupam;
Rajgarhia, Shilpy

Publication type:

Article

Development of a HPLC Method for Analysis of a Combination of Clofazimine, Isoniazid, Pyrazinamide, and Rifampicin Incorporated into a Dermal Self-Double-Emulsifying Drug Delivery System.

Published in:

Methods & Protocols, 2023, v. 6, n. 6, p. 104, doi. 10.3390/mps6060104

By:

Staden, Daniélle van;
Haynes, Richard K.;
Van der Kooy, Frank;
Viljoen, Joe M.

Publication type:

Article

A case of Simultaneous Tuberculous Lymphadenitis and Pleurisy a Young Man from Indonesia.

Published in:

Bosphorus Medical Journal / Boğaziçi Tıp Dergisi, 2022, v. 9, n. 3, p. 199, doi. 10.14744/bmj.2022.96658

By:

Musayeva, Nurjahan;
Kanbur, Ayşenur Yalçıntaş

Publication type:

Article